BMY 241220 55.00C (BMY241220C55000) Stock Options, News & Quotes

US OptionsDetailed Quotes

BMY241220C55000

Watchlist

1.24
-0.43-25.75%

15min DelayClose Dec 13 16:00 ET

1.61High0.84Low

Intraday

5D
Daily

News

Bristol-Myers Squibb (NYSE:BMY) Will Pay A Larger Dividend Than Last Year At $0.62
Yahoo FinanceDec 15 07:21 ET
Bristol-Myers Squibb Notified Century Therapeutics On Dec 12 To Terminate Collaboration Agreement, Effective March 12, 2025; Co To Evaluate Opportunities In AML And Multiple Myeloma In The Context Of The Ongoing Strategic Review Of Century's...
BenzingaDec 13 17:07 ET
Express News | Century Therapeutics - to Evaluate Opportunities in Aml and Multiple Myeloma
ReutersDec 13 17:03 ET
Express News | Century Therapeutics - Termination Effective March 12, 2025
ReutersDec 13 17:03 ET
Express News | Century Therapeutics- Bms Notified Co on Dec 12 to Terminate Collaboration Agreement With Century Therapeutics
ReutersDec 13 17:03 ET
Weekly Buzz: Tech stocks hit high scores on ominous day
Kevin TraversDec 13 16:29 ET

Comments

10xStockPicks

10 hours ago

A.i Predicts Big Pharma Will Soon Acquire Esperion Therapeutics for $12 to $16 A share, Current Price $2.25

$Esperion Therapeutics (ESPR.US)$ Acquiring Esperion Therapeutics could be a strategic move for a big pharmaceutical company for several compelling reasons. Here are the main factors that suggest an acquisition could be beneficial for a larger player in the pharmaceutical industry:
1. Unique Market Position in Statin Alternatives
– Addressing Statin Intolerance: There are millions of statin...

Meltyy

Dec 10 05:36

🚀 10 Upcoming PDUFAs in December! ❄️

Buckle up! See FDA PDUFA update 👇
$Ionis Pharmaceuticals (IONS.US)$ ⇨ IONIS-APOCIII-LRx (Olezarsen)
$ZLDPF ⇨ Glepaglutide
$Rhythm Pharmaceuticals (RYTM.US)$ ⇨ IMCIVREE™ (Setmelanotide)
$Mirum Pharmaceuticals (MIRM.US)$ ⇨ Chenodal® (chenodiol)
$Checkpoint Therapeutics (CKPT.US)$ ⇨ Cosibelimab (CK-301)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinecerfont capsule
$Bristol-Myers Squibb (BMY.US)$ ⇨ Opdivo® Subcutaneous (nivolumab + hyaluronidase)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinecerfont oral solution
$BeiGene (BGNE.US)$ ⇨ Tisleli...

Meltyy

Dec 5 06:32

🚀 12 upcoming PDUFAs in December ❄️

Buckle up! See FDA PDUFA update 👇🧵
$Ionis Pharmaceuticals (IONS.US)$ ⇨ IONIS-APOCIII-LRx (Olezarsen)
$ZLDPF ⇨ Glepaglutide
$Rhythm Pharmaceuticals (RYTM.US)$ ⇨ IMCIVREE™ (Setmelanotide)
$Mirum Pharmaceuticals (MIRM.US)$ ⇨ Chenodal® (chenodiol)
$Checkpoint Therapeutics (CKPT.US)$ ⇨ Cosibelimab (CK-301)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinecerfont capsule
$Bristol-Myers Squibb (BMY.US)$ ⇨ Opdivo® Subcutaneous (nivolumab + hyaluronidase)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinece...

Kevin Travers

Nov 11 15:20

Columns Triple Treat Monday Sees Indecies Hit High Closes | Wall Street Today

Happy Monday, November 11th. The market climbed to a trifecta of closing highs for indices. The S&P 500 broke through 6k Friday and traded above the historic mark again Monday before the market pulled back in the afternoon.
Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ traded +10 bps, the $Dow Jones Industrial Average (.DJI.US)$ climbed 69 bps, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.06%.
MACRO
In macroecon...

Bitcoin breaks the $100,000 again: How high could it go?

Kevin Travers

Nov 11 09:49

Columns Market Opens to Fresh Highs | Live Stock

Good morning, traders. Happy Monday, November 11th. The market is climbing, but some tech firms are pulling back after hitting post-election records. The S&P 500 broke through 6,000 Friday and traded above the historic mark again Monday.
My name is Kevin Travers; here is the news and animal spirits moving markets today.
$Monolithic Power Systems (MPWR.US)$ shares fell 22%, the lowest decliner on the S&P 500 and Nasdaq, after a report from analysts at Edgew...

Trump trade: Bitcoin hit record highs and Tesla hits $1 trillion market cap